Next-generation Precision Oncology Trials: Innovation and Future Directions

Oncology Symposium
Next-generation Precision Oncology Trials: Innovation and Future Directions

Date: 19 Sep 2025, Friday | Time: 1525 - 1655 | Track Type: Symposium | Venue: L1-S3, Level 1, Academia

1. Personalized Treatment: The symposium will highlight the importance of tailoring cancer therapies to individual patients based on their unique genetic and molecular profiles, thereby enhancing treatment efficacy and minimizing adverse effects.

2. Emerging Technologies: With rapid advancements in genomics, artificial intelligence, and data analytics, the symposium will explore how these technologies can be leveraged to improve clinical trial designs and patient stratification.

3. Collaborative Research: By fostering collaboration among various stakeholders in the oncology field, the symposium aims to accelerate the development of new therapies and improve the overall landscape of cancer treatment.

4. Translating Research to Impactful Patient Outcomes: Role of ACTRIS

This segment explores ACTRIS’ role in enabling translational research, development and manufacturing of cellular-based therapeutics. This includes clinical service provision and commercialisation by serving the healthcare, academic and industrial sectors, ultimately improving patient outcomes.

TOPIC 1:
Translating Research to Impactful Patient Outcomes: Role of ACTRIS
Speaker: Adj Assoc Prof Yap Eng Soo

TOPIC 2:
Diagnostic Approaches in Tumor Profiling
Speaker: Dr Timothy Tay Kwang Yong

TOPIC 3:
Integrating AI in Precision Oncology
Speaker: Dr Joe Yeong Poh Sheng

TOPIC 4:
Transcriptomic Profiling and Analysis for Precision Oncology
Speaker: Dr Anders Skanderup

TOPIC 5:
Genomic Profiling in Cancer Treatment – Molecular Tumor Board
Speaker: Dr Ang Su Fen

TOPIC 6:
Future Directions in Clinical Trials
Speaker: Prof Daniel Tan Shao Weng